Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
5
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
5
×
life sciences
5
×
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
5
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer immunotherapy
clinical trials
pfizer
president trump
startups
alexion pharmaceuticals
bristol-myers squibb
deals
eli lilly
fda
johnson & johnson
What
drug
5
×
roundup
bio
alzheimer’s
annual
attention
biotech
companies
plan
prices
advantages
ahead
ambien
american
approved
asco
assessed
attendees
bar
brings
camp’s
cancer
cash
chicago
city
clinical
combinations
communities
community’s
conference
days
different
digital
disease
epidemic
esmo
europe
expanding
expect
fail
Language
unset
Current search:
drug
×
biotech
×
" life sciences "
×
" raleigh-durham top stories "
×
cancer
×
investing
×
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More